VR Visualization Enhances Pancreatic Cancer Resectability Assessment

Overview

This study evaluates the use of Specto VR™, a PACS-compatible virtual reality software, for interactive 3D visualization of abdominal CT and MRI scans in pancreatic ductal adenocarcinoma (PDAC). Clinicians from various specialties demonstrated improved anatomical understanding and potential for enhanced assessment of vascular involvement and tumor resectability.

Background

Pancreatic ductal adenocarcinoma (PDAC) resectability assessment relies heavily on two-dimensional cross-sectional imaging, which suffers from low inter-observer agreement. Current guidelines categorize PDAC into resectable, borderline resectable, and locally advanced disease based on vascular involvement seen on contrast-enhanced CT or MRI. Virtual reality (VR) technology offers immersive 3D visualization of imaging data, potentially improving anatomical comprehension and surgical planning. Specto VR™ software enables real-time rendering and interactive manipulation of CT and MRI datasets, facilitating detailed study of complex anatomy in a VR environment.

Data Highlights

The study included 34 patients with pathologically confirmed PDAC, balanced across resectability categories (Resectable, Borderline Resectable, Locally Advanced) per NCCN guidelines. Participants included clinicians of varying experience and specializations. Anatomical structure identification accuracy and usability feedback were collected during VR sessions. Multidisciplinary team outcomes and postoperative data were also analyzed to correlate VR assessments with clinical decisions.

Key Findings

• Clinicians across specialties successfully identified key anatomical structures using immersive 3D VR visualization of CT and MRI scans.
• VR enhanced anatomical understanding compared to traditional 2D imaging, potentially reducing inter-observer variability in PDAC resectability assessment.
• Expert abdominal surgeons and radiologists found VR useful for evaluating vascular involvement critical to surgical planning.
• The VR system allowed simultaneous viewing of original imaging datasets and 3D rendered models with interactive cutting planes, improving spatial orientation.
• Participants reported the VR tool was well tolerated and intuitive after brief acclimatization and instruction.

Clinical Implications

Incorporating VR visualization into preoperative assessment may improve accuracy and confidence in determining PDAC resectability, aiding multidisciplinary decision-making. The interactive 3D environment facilitates better understanding of complex vascular anatomy, potentially optimizing surgical planning and patient outcomes. Wider clinical adoption of VR tools like Specto VR™ could enhance training and standardize imaging interpretation.

Conclusion

This study demonstrates that advanced VR visualization of abdominal CT and MRI scans is a promising tool to improve anatomical comprehension and resectability assessment in pancreatic cancer. Further integration into clinical workflows may enhance surgical and oncological treatment planning.

References

1. Specto VR™ Validation Studies 2021 -- VR in Ophthalmology and MRCP Imaging
2. NCCN Guidelines 2023 -- Pancreatic Adenocarcinoma Resectability Criteria
3. Inter-observer Variability in PDAC Imaging Assessment 2020 -- Fleiss κ Analysis